Menu
Back to Journals » OncoTargets and Therapy » Volume 15
Original Research
Combination Use of First-Line Afatinib and Proton-Pump Inhibitors Reduces Overall Survival Among Patients with EGFFR Mutant Lung Cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 3,003 | Dovepress* | 2,604+ | 91 | 2,695 | |
| PubMed Central* | 399 | 100 | 499 | ||
| Totals | 3,003 | 191 | 3,194 | ||
| *Since 28 December 2022 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 0 | 0 | 0 | 2 | 2 |
View citations on PubMed Central and Google Scholar